U.S. market Closed. Opens in 17 hours 7 minutes

ITCI | Intra-Cellular Therapies, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 75.21 - 76.60
52 Week Range 45.50 - 84.89
Beta 0.92
Implied Volatility 33.16%
IV Rank 4.58%
Day's Volume 407,180
Average Volume 1,028,748
Shares Outstanding 105,667,000
Market Cap 7,952,498,420
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2014-01-07
Valuation
Profitability
Growth
Health
P/E Ratio -87.51
Forward P/E Ratio N/A
EPS -0.86
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 610
Country USA
Website ITCI
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.
*Chart delayed
Analyzing fundamentals for ITCI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is strong. For more detailed analysis please see ITCI Fundamentals page.

Watching at ITCI technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ITCI Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙